Diasend

Chicago, United States Founded: 2005 • Age: 21 yrs Acquired By Glooko
Web and mobile solution for diabetic patients

About Diasend

Diasend is a Healthcare company based in Chicago (United States) founded in 2005, and was acquired by Glooko in September 2016. Web and mobile solution for diabetic patients. The company has 10 employees. Its focus areas include HealthTech, Disease Self Management, Diabetes and Monitoring. Its legal entity is Diasend, Inc. Its competitors include Verily, Glooko and Memora Health; 3 of its 3 listed competitors have raised funding.

Company details

Diasend is a healthcare company seeking to simplify communication between care providers and patients for diabetes management. It develops diasend Clinic for providers to store and access data of all their diabetic patients at one place. For patients, it offers diasend Personal which can be accessed via web or mobile and connected to devices like glucometers, insulin pumps, etc. The company is present in 15 countries and its solutions are available in over 10 different languages. The company claims that almost 2000 clinics around the world use diasend and around 350,000 patients are benefitting from their solutions. Its platform is compatiable with devices like glucose meters, insulin pumps and CGMs and enables integration with EMR data.

  • Headquarters Chicago, United States
  • Employees 10
  • Stage Acquired
  • Sectors
    Healthcare
  • Website diasend.com
  • Social LinkedIn X Facebook
  • Acquired by Glooko (Sep 2016)
  • Legal Name Diasend, Inc.
Key Metrics
  • Latest Funding Round
    $192.46K (USD), Grant

    Jan 2017

  • Investors
    Glooko

    & 1 more

  • Employee Count
    10
  • Acquired by
    Glooko

    (Sep 2016)

Funding Insights of Diasend

  • Total Rounds 1
  • Last Round Grant β€” $192,460
  • First Round $192,460

    (Jan 2017)

  • Investors Count 1

All 1 funding rounds of Diasend with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2017$192,460Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Diasend

Diasend has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Glooko and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Diabetes management is enabled via glucose meters and mobile apps.
2010glooko.comPalo Alto, United States
Premium access

Investor details for Diasend

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Diasend

3 dated milestones of Diasend across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Diasend is founded.
  2. Exit Acquired by Glooko.
  3. Funding First funding round of $192K.

Competitors of Diasend

Diasend has 3 listed competitors in our database, 3 of them funded. They include Verily, Glooko and Memora Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
glooko.com2010Palo Alto, United States$201M121
Diabetes management is enabled via glucose meters and mobile apps.
memorahealth.com2015Boston, United States$80.65M91
Mobile messaging platform is utilized for chronic disease management.
Premium access

Detailed competitors of Diasend

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Diasend

The website of Diasend (diasend.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▼ 12.8% vs previous month

Similar websites

Websites whose visitors overlap most with Diasend. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
animas.com
100%
View details
tudiabetes.org
tudiabetes.org
99%
#562,103–
myfreestyle.com
myfreestyle.com
83%
–
bayerglucofacts.com
bayerglucofacts.com
79%
–
nightscout.info
nightscout.info
78%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Diasend

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Diasend (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Diasend

Premium access

Complete news archive for Diasend

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Diasend

Diasend was founded in 2005 and raised its 1st funding round 12 years after it was founded.

Diasend is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Diasend has 10 employees.

Diasend is a healthcare company seeking to simplify communication between care providers and patients for diabetes management. It develops diasend Clinic for providers to store and access data of all their diabetic patients at one place. For patients, it offers diasend Personal which can be accessed via web or mobile and connected to devices like glucometers, insulin pumps, etc. The company is present in 15 countries and its solutions are available in over 10 different languages. The company claims that almost 2000 clinics around the world use diasend and around 350,000 patients are benefitting from their solutions. Its platform is compatiable with devices like glucose meters, insulin pumps and CGMs and enables integration with EMR data.

Diasend's top competitors include Verily, Glooko and Memora Health.

Diasend has 2 investors. Key investors include Glooko, and European Union.

Diasend operates through Diasend, Inc..

Yes. Diasend was acquired by Glooko in September 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available